Novel drug delivery system produced by centrifugal technologies – composed to minimize adverse immune reactions and designed for optimised therapeutic effects

Projektinformationen

DECENT AID

ID Finanzhilfevereinbarung: 324275

Projekt abgeschlossen

Startdatum 1 April 2013

Enddatum 31 März 2017

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 1 492 545,10

EU-Beitrag € 1 492 545,10

Koordiniert durch

ABNOBA GMBH
Germany